Skip to content

Clinical trials

Phase 1 Thrombocythemia, Essential trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Phase: Phase 1 Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20041
20053
20061
20072
20082
20091
20103
20122
20141
20151
20181
20192
20202
20211
20233
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting7
Terminated6
Active, not recruiting4
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
Incyte Corporation5
Eli Lilly and Company3
Northwestern University3
California Cancer Consortium2
AbbVie1
Alliance for Clinical Trials in Oncology1
Astex Pharmaceuticals, Inc.1
BioCryst Pharmaceuticals1
Case Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential47
Primary Myelofibrosis43
Polycythemia Vera37
Myeloproliferative Disorders36
Leukemia, Myeloid, Acute28
Leukemia, Myelomonocytic, Chronic26
Precursor Cell Lymphoblastic Leukemia-Lymphoma25
Leukemia, Lymphocytic, Chronic, B-Cell23
Myelodysplastic Syndromes22
Burkitt Lymphoma21

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.